As many of you know, I am a big Yankees fan. My favorite Yankee is Lou Gehring. Great hitter. Better person. Class act. Amyotrophic lateral sclerosis is also known as ALS or Lou Gehrig’s disease.

Well, he is smiling down on us today because of the progress with new treatments for amyotrophic lateral sclerosis. The illness is often known as ALS or Lou Gehrig’s disease.

NPR reported that a combination of two experimental drugs appears to slow the decline in patients. Daily doses of a two-drug combination called AMX0035 scored several points higher on a standard measure of function. The report is in the Sept. 3 issue of The New England Journal of Medicine.

Patients with Lou Gehrig’s disease kept the ability to walk, breathe and do other functions longer than subjects who took a placebo in a recent trial. This new treatment gives hope to those suffering from the disease.